The DOI matches its Crossref record; 256 of the 256 references it cites were found in a registry or an index.
Ocular Drug Delivery
Open accessAbstract
Ocular drug delivery has been a major challenge to pharmacologists and drug delivery scientists due to its unique anatomy and physiology. Static barriers (different layers of cornea, sclera, and retina including blood aqueous and blood-retinal barriers), dynamic barriers (choroidal and conjunctival blood flow, lymphatic clearance, and tear dilution), and efflux pumps in conjunction pose a significant challenge for delivery of a drug alone or in a dosage form, especially to the posterior segment. Identification of influx transporters on various ocular tissues and designing a transporter-targeted delivery of a parent drug has gathered momentum in recent years. Parallelly, colloidal dosage forms such as nanoparticles, nanomicelles, liposomes, and microemulsions have been widely explored to overcome various static and dynamic barriers. Novel drug delivery strategies such as bioadhesive gels and fibrin sealant-based approaches were developed to sustain drug levels at the target site. Designing noninvasive sustained drug delivery systems and exploring the feasibility of topical application to deliver drugs to the posterior segment may drastically improve drug delivery in the years to come. Current developments in the field of ophthalmic drug delivery promise a significant improvement in overcoming the challenges posed by various anterior and posterior segment diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This method avoids complications of first-pass metabolism and has the advantage of easy administration, sometimes by the patients themselves. However, barriers, such as the pre-corneal tear film, the structure of the cornea, limited volume, lacrimal drainage system, reflex tearing, and aqueous outflow of the eye, reduce the bioavailability of the product to around 5% or less.35,118,119”
From Gene Therapy for Retinal Degenerative Diseases: Progress, Challenges, and Future Directions (2023) · cites this paper as [119]
In the citing paper
“Most gene therapy viral vectors given intravitreally, fail to adequately transduce photoreceptors and RPE, due to the inner limiting membrane that divides the vitreous from the retina.1,15,119,127”
From Gene Therapy for Retinal Degenerative Diseases: Progress, Challenges, and Future Directions (2023) · cites this paper as [119]
In the citing paper
“Despite these advantages, intravitreal injections also carry risks of adverse reactions, including inflammation, endophthalmitis, increased intraocular pressure, retinal detachment, hemorrhage, and cataracts, and due to the repeated use of these injections in various treatments, patient compliance can become an issue.119,127,129”
From Gene Therapy for Retinal Degenerative Diseases: Progress, Challenges, and Future Directions (2023) · cites this paper as [119]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Block copolymer micelles for drug delivery: design, characterization and biological significance
Kataoka, K., Harada, A., & Nagasaki, Y. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00124-1 · Cited by 3,506
Cyclodextrins and their uses: a review
Del Valle, E. M. M. (2004) · Process Biochemistry · doi:10.1016/s0032-9592(03)00258-9 · Cited by 3,375
Cyclodextrins and their pharmaceutical applications
Loftsson, Þ., & Duchêne, D. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.10.044 · Cited by 1,766
Prodrugs: design and clinical applications
Rautio, J., Kumpulainen, H., Heimbach, T., Oliyai, R., Oh, D.-M., Järvinen, T., & Savolainen, J. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2468 · Cited by 1,681
Tomalia, D. A. (2005) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2005.01.007 · Cited by 1,115
Challenges and obstacles of ocular pharmacokinetics and drug delivery
Urtti, A. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.07.027 · Cited by 1,003
Permeability of cornea, sclera, and conjunctiva: A literature analysis for drug delivery to the eye
Prausnitz, M. R., & Noonan, J. S. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js9802594 · Cited by 630
Recent Perspectives in Ocular Drug Delivery
Gaudana, R., Jwala, J., Boddu, S., & Mitra, A. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9694-0 · Cited by 600
Self-citationSieving, P. A., Caruso, R. C., Tao, W., Coleman, H. R., Thompson, D. J. S., Fullmer, K. R., & Bush, R. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600236103 · Cited by 591
Topical Ocular Drug Delivery: Recent Developments and Future Challenges
Lee, V. H. L., & Robinson, J. R. (1986) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.1986.2.67 · Cited by 504
Cited by
Sorted by citations
Items 401–500 of 1,000
Lai, J. (2013) · Drug Design Development and Therapy · doi:10.2147/dddt.s53759 · Cited by 38
Nor, N. M., Guo, C. X., Rupenthal, I. D., Chen, Y.-S., Green, C. R., & Acosta, M. L. (2018) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.17-22829 · Cited by 38
Ophthalmic and Otic Drug Administration: Novel Approaches and Challenges
Desai, A. R., Shukla, M. R., Maulvi, F. A., & Ranch, K. M. (2019) · Springer eBooks · doi:10.1007/978-981-13-3642-3_10 · Cited by 38
The prominence of the dosage form design to treat ocular diseases
Campos, P. M., Petrilli, R., & Lopez, R. F. V. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119577 · Cited by 38
The Emerging Role of Topical Ocular Drugs to Target the Posterior Eye
Wang, L., Zhou, M., & Zhang, H. (2021) · Ophthalmology and Therapy · doi:10.1007/s40123-021-00365-y · Cited by 43
Toward the practical implementation of eye-related bioavailability prediction models
Pepić, I., Lovrić, J., Cetina‐Čižmek, B., Reichl, S., & Filipović‐Grčić, J. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.08.002 · Cited by 38
Novel Drug Delivery Systems to Improve the Treatment of Keratitis
Polat, H. K., Kurt, N., Aytekin, E., Pehlivan, S. B., & Çalış, S. (2022) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2021.0127 · Cited by 37
Račić, A., & Krajišnik, D. R. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020470 · Cited by 39
Peptide and Protein-Based Therapeutic Agents∗
Joseph, M. A., Trinh, H. M., & Mitra, A. K. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-42978-8.00007-3 · Cited by 37
Self-citationTherapeutic Systems and Technologies: State-of-the-Art Applications, Opportunities, and Challenges
Almekkawy, M. K., Zderic, V., Chen, J., Ellis, M. D., Haemmerich, D., Holmes, D. R., Linte, C. A., Panescu, D., Pearce, J. A., & Prakash, P. (2019) · IEEE Reviews in Biomedical Engineering · doi:10.1109/rbme.2019.2908940 · Cited by 36
iRGD decorated liposomes: A novel actively penetrating topical ocular drug delivery strategy
Huang, H., Yang, X., Li, H., Lu, H., Oswald, J. T., Liu, Y., Zeng, J., Jin, C., Peng, X., Liu, J., et al. (2020) · Nano Research · doi:10.1007/s12274-020-2980-9 · Cited by 37
Shukr, M. H., Ismail, S., El-Hossary, G. G., & Elshazly, A. H. M. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102333 · Cited by 38
Bioengineered Biomimetic and Bioinspired Noninvasive Drug Delivery Systems
Rahamim, V., & Azagury, A. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202102033 · Cited by 38
Zaghloul, N., Hoffy, N. M. E., Mahmoud, A. A. K., & ElKasabgy, N. A. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14030470 · Cited by 37
Vivero-Lopez, M., Sparacino, C., Quelle‐Regaldie, A., Sanchez, L. E., Candal, E., Barreiro‐Iglesias, A., Huete‐Toral, F., Carracedo, G., Otero, A., Concheiro, Á., et al. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.122281 · Cited by 37
Gene therapy for ocular diseases meditated by ultrasound and microbubbles (Review)
WAN, C., LI, F., & LI, H. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4054 · Cited by 36
Pelusi, L., Mandatori, D., Mastropasqua, L., Agnifili, L., Allegretti, M., Nubile, M., & Pandolfi, A. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020625 · Cited by 39
DES-igning the future of drug delivery: A journey from fundamentals to drug delivery applications
Kapre, S., Palakurthi, S. S., Jain, A., & Palakurthi, S. (2024) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2024.124517 · Cited by 36
Gai, X., Cheng, L., Li, T., Liu, D., Wang, Y., Wang, T., Pan, W., & Yang, X. (2017) · AAPS PharmSciTech · doi:10.1208/s12249-017-0872-4 · Cited by 36
RETRACTED ARTICLE: Bimatoprost Imprinted Silicone Contact Lens to Treat Glaucoma
Yan, F., Liu, Y., Han, S., Zhao, Q., & Liu, N. (2020) · AAPS PharmSciTech · doi:10.1208/s12249-020-1622-6 · Cited by 36
RetractedFayyaz, A., Ranta, V., Toropainen, E., Vellonen, K., Valtari, A., Puranen, J., Ruponen, M., Gardner, I. B., Urtti, A. O., Jamei, M., et al. (2020) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2020.105553 · Cited by 36
Mohammadi, M., Elahimehr, Z., & Mahboobian, M. M. (2021) · Current Eye Research · doi:10.1080/02713683.2021.1929328 · Cited by 34
Jounaki, K., Makhmalzadeh, B. S., Feghhi, M., & Heidarian, A. (2021) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2021.105991 · Cited by 36
Neves, L. F. F., Duan, J., Voelker, A., Khanal, A., McNally, L. R., Steinbach-Rankins, J. M., & Ceresa, B. P. (2016) · Journal of Microencapsulation · doi:10.1080/02652048.2016.1202343 · Cited by 36
Recent advances in poly(amino acids), polypeptides, and their derivatives in drug delivery
Yuan, H., Jiang, M., Fang, H., & Tian, H. (2024) · Nanoscale · doi:10.1039/d4nr04481a · Cited by 38
TGF-β2–Mediated Ocular Hypertension Is Attenuated in SPARC-Null Mice
Swaminathan, S. S., Oh, D., Kang, M. H., Shepard, A. R., Pang, I.-H., & Rhee, D. J. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-12463 · Cited by 35
Kapanigowda, U. G., Sreeharsha, N., Ramaiah, B., & Boggarapu, P. R. (2015) · DARU Journal of Pharmaceutical Sciences · doi:10.1186/s40199-015-0132-7 · Cited by 35
Bachu, R. D., Stepanski, M., Alzhrani, R. M., Jung, R., & Boddu, S. H. S. (2018) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2017.0082 · Cited by 35
Alaimo, A., Santo, M. C. D., Rubio, A. P. D., Chaufan, G., Liñares, G. G., & Pérez, O. E. (2019) · Archives of Toxicology · doi:10.1007/s00204-019-02637-w · Cited by 39
Saliba, J. B., Vieira, L. C., Fernandes-Cunha, G. M., da Silva, G. R., Fialho, S. L., Silva‐Cunha, A., Bousquet, E., Naud, M., Ayres, E., Oréfice, R. L., et al. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-18127 · Cited by 35
Magnetic micropump embedded in contact lens for on-demand drug delivery
Wang, C., & Park, J. (2020) · Micro and Nano Systems Letters · doi:10.1186/s40486-019-0101-x · Cited by 35
Shahab, M. S., Rizwanullah, M., & Imam, S. S. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.103062 · Cited by 35
Abarca, E. M., Salmon, J. H., & Gilger, B. C. (2013) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2013.0063 · Cited by 35
Jakubiak, P., Reutlinger, M., Mattei, P., Schuler, F., Urtti, A. O., & Alvarez‐Sánchez, R. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01281 · Cited by 35
Obeidat, W. M., & Lahlouh, I. K. (2025) · AAPS PharmSciTech · doi:10.1208/s12249-025-03100-z · Cited by 41
Evaluation of topical hesperetin matrix film for back-of-the-eye delivery
Adelli, G. R., Hingorani, T., Punyamurthula, N. S., Balguri, S. P., & Majumdar, S. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.02.006 · Cited by 34
Rajawat, G. S., Shinde, U. A., & Nair, H. A. (2016) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2016.08.006 · Cited by 34
Cummings, C., Fein, K. C., Murata, H., Ball, R. L., Russell, A. J., & Whitehead, K. A. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.04.035 · Cited by 34
Prima, G. D., Bongiovì, F., Palumbo, F. S., Pitarresi, G. L., Licciardi, M., & Giammona, G. (2018) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2018.10.028 · Cited by 34
Design and Evaluation of Ophthalmic Delivery Formulations
Soni, V., Pandey, V., Tiwari, R., Asati, S., & Tekade, R. K. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-817909-3.00013-3 · Cited by 35
Advances in ophthalmic preparation: the role of drug nanocrystals and lipid-based nanosystems
Peters, M. C. C., Neto, E. D. S., Monteiro, L. M., Yukuyama, M. N., Machado, M. G. M., de Oliveira, I. F., Zanin, M. H. A., Löbenberg, R., & Bou‐Chacra, N. A. (2019) · Journal of drug targeting · doi:10.1080/1061186x.2019.1663858 · Cited by 34
Fabiano, A., Piras, A. M., Guazzelli, L., Storti, B., Bizzarri, R., & Zambito, Y. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11120623 · Cited by 34
Horita, S., Watanabe, M., Katagiri, M., Nakamura, H., Haniuda, H., Nakazato, T., & Kagawa, Y. (2019) · Pharmacology Research & Perspectives · doi:10.1002/prp2.545 · Cited by 36
Chen, Z., Yang, M., Wang, Q., Bai, J., McAlinden, C., Skiadaresi, E., Zhang, J., Pan, L., Mei, C., Zeng, Z., et al. (2020) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2020.117216 · Cited by 34
Glaucoma: Management and Future Perspectives for Nanotechnology-Based Treatment Modalities
Hoffy, N. M. E., Azim, E. A. A., Hathout, R. M., Fouly, M. A. K., & Elkheshen, S. A. (2020) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2020.105648 · Cited by 34
Hyaluronan-Cholesterol Nanogels for the Enhancement of the Ocular Delivery of Therapeutics
Zoratto, N., Forcina, L., Matassa, R., Mosca, L., Familiari, G., Musarò, A., Mattei, M., Coviello, T., Meo, C. D., & Matricardi, P. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13111781 · Cited by 34
Alhakamy, N. A., Hosny, K. M., Aldryhim, A. Y., Rizg, W. Y., Eshmawi, B. A., Bukhary, H. A., Murshid, S. S. A., & Khallaf, R. A. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.103373 · Cited by 34
Nanocarriers for ocular drug delivery: Recent advances and future opportunities
Amrutkar, C. S., & Patil, S. B. (2023) · Indian Journal of Ophthalmology · doi:10.4103/ijo.ijo_1893_22 · Cited by 34
Carbohydrate Based Nanoparticles for Drug Delivery Across Biological Barriers
Peptu, C. A., Ochiuz, L., Alupei, L., Peptu, C., & Popa, M. (2014) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2014.1950 · Cited by 34
Ultrasound-enhanced ocular delivery of dexamethasone sodium phosphate: an in vivo study
Nabili, M., Shenoy, A., Chawla, S., Mahesh, S. P., Liu, J., Geist, C. E., & Zderic, V. (2014) · Journal of Therapeutic Ultrasound · doi:10.1186/2050-5736-2-6 · Cited by 34
Liu, D., Li, J., Cheng, B., Wu, Q., & Pan, H. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00069 · Cited by 34
Glucocorticoid receptor GRβ regulates glucocorticoid-induced ocular hypertension in mice
Patel, G. C., Liu, Y., Millar, J. C., & Clark, A. F. (2018) · Scientific Reports · doi:10.1038/s41598-018-19262-9 · Cited by 34
Naik, S., Shreya, A. B., Raychaudhuri, R., Pandey, A., Lewis, S. A., Hazarika, M., Bhandary, S. V., Rao, B. S. S., & Mutalik, S. (2021) · Life Sciences · doi:10.1016/j.lfs.2020.118712 · Cited by 33
Nanozymes for Treating Ocular Diseases
Wong, K., Wong, M., & Liu, J. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202401309 · Cited by 33
Cationic-motif-modified exosomes for mRNA delivery to retinal photoreceptors
Cotto, H. A. M., Pathrikar, T. V., Hakim, B., Baby, H. M., Zhang, H., Zhao, P., Ansaripour, R., Amini, R., Carrier, R. L., & Bajpayee, A. G. (2024) · Journal of Materials Chemistry B · doi:10.1039/d4tb00849a · Cited by 33
Exploring Hydrogel Nanoparticle Systems for Enhanced Ocular Drug Delivery
Arabpour, Z., Salehi, M., An, S., Moghtader, A., Anwar, K. N., Baharnoori, S. M., Shah, R. J., Abedi, F., & Djalilian, A. R. (2024) · Gels · doi:10.3390/gels10090589 · Cited by 34
Topical Ocular Drug Delivery: The Impact of Permeation Enhancers
Santos, G., Delgado, E., Silva, B., Bráz, B. S., & Gonçalves, L. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17040447 · Cited by 37
Wu, X., Yu, G.-P., Luo, C., Maeda, A., Zhang, N., Sun, D., Zhou, Z., Puntel, A., Palczewski, K., & Lu, Z. (2013) · ACS Nano · doi:10.1021/nn4054107 · Cited by 33
Preclinical challenges for developing long acting intravitreal medicines
Awwad, S., Henein, C., Ibeanu, N., Khaw, P. T., & Brocchini, S. (2020) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2020.05.005 · Cited by 33
Ibrahim, M. M., Maria, D. N., Wang, X., Simpson, R. N., Hollingsworth, T., & Jablonski, M. M. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12080704 · Cited by 33
Pharmacological Potential of Small Molecules for Treating Corneal Neovascularization
Barry, Z., Park, B., & Corson, T. W. (2020) · Molecules · doi:10.3390/molecules25153468 · Cited by 36
Vadlapudi, A. D., Vadlapatla, R. K., Pal, D., & Mitra, A. K. (2012) · The AAPS Journal · doi:10.1208/s12248-012-9399-5 · Cited by 33
Self-citationGiacoia, G. P., Taylor‐Zapata, P., & Zajicek, A. (2012) · Clinical Therapeutics · doi:10.1016/j.clinthera.2012.09.013 · Cited by 33
Ashique, S., Mishra, N., Mohanto, S., Gowda, B. H. J., Kumar, S., Raikar, A. S., Masand, P., Garg, A., Goswami, P. K., & Kahwa, I. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e23810 · Cited by 32
RetractedNext generation therapeutics for retinal neurodegenerative diseases
Appell, M. B., Pejavar, J., Pasupathy, A., Rompicharla, S. V. K., Abbasi, S., Malmberg, K., Kolodziejski, P., & Ensign, L. M. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.01.063 · Cited by 33
Neaz, S., Alam, M. M., & Imran, A. B. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e39917 · Cited by 34
Lidich, N., Garti-Levy, S., Aserin, A., & Garti, N. (2018) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2018.09.063 · Cited by 32
Shatz-Binder, W., Aaronson, J., Yohe, S. T., Kelley, R. F., & Kalia, Y. N. (2018) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2019.1553953 · Cited by 32
Jerkins, G. W., Pattar, G. R., & Kannarr, S. R. (2020) · Clinical ophthalmology · doi:10.2147/opth.s228070 · Cited by 36
Jayaraman, M. S., Bharali, D. J., Sudha, T., & Mousa, S. A. (2012) · Europe PMC (PubMed Central) · Cited by 31
Seyfoddin, A., Sherwin, T., Patel, D. V., McGhee, C. N. J., Rupenthal, I. D., Taylor, J. A., & Al‐Kassas, R. (2016) · Current Drug Delivery · doi:10.2174/1567201813666151116142752 · Cited by 31
Zou, M., Jin, R., Hu, Y., Zhang, Y., Wang, H., Liu, G., Nie, Y., & Wang, Y. (2019) · Journal of Materials Chemistry B · doi:10.1039/c9tb00939f · Cited by 31
Bíró, T., & Aigner, Z. (2019) · Scientia Pharmaceutica · doi:10.3390/scipharm87030015 · Cited by 31
Enhanced topical corticosteroids delivery to the eye: A trade-off in strategy choice
Shen, L., Fang, G., Tang, B., & Zhu, Q. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.09.022 · Cited by 32
Pressure-Triggered Microfluidic Contact Lens for Ocular Drug Delivery
Du, Z., Zhao, G., Wang, A., Sun, W., & Mi, S. (2022) · ACS Applied Polymer Materials · doi:10.1021/acsapm.2c01118 · Cited by 31
Wei, D., Pu, N., Li, S., Wang, Y., & Tao, Y. (2023) · Drug Delivery · doi:10.1080/10717544.2023.2165736 · Cited by 31
Development of Curcumin Based Ophthalmic Formulation
G. (2012) · American Journal of Infectious Diseases · doi:10.3844/ajidsp.2012.41.49 · Cited by 31
Penetration of β-Blockers through Ocular Membranes in A1bino Rabbits
Sasaki, H., Igarashi, Y., Nagano, T., Yamamura, K., Nishida, K., & Nakamura, J. (1995) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1995.tb05726.x · Cited by 31
Gao, D., Da, Z., Yang, K., & Shi, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.882803 · Cited by 32
Pimenta, A., Valente, A., Pereira, J. R. P., Pereira, J., Filipe, H. P., Mata, J. L., Colaço, R., Saramago, B., & Serro, A. P. (2016) · Drug Delivery and Translational Research · doi:10.1007/s13346-016-0303-1 · Cited by 30
Eyelid skin as a potential site for drug delivery to conjunctiva and ocular tissues
See, G. L., Sagesaka, A., Sugasawa, S., Todo, H., & Sugibayashi, K. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.09.070 · Cited by 30
Silva, R. O., da Costa, B. L., da Silva, F. R., da Silva, C. N., de Paiva, M. R. B., Dourado, L. F. N., Malachias, Â., Araújo, A. A. D. S., Nunes, P. S., & Silva‐Cunha, A. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.118466 · Cited by 31
Rapid assessment of ocular drug delivery in a novel ex vivo corneal model
Begum, G., Leigh, T., Courtie, E. F., Moakes, R. J. A., Butt, G. F., Ahmed, Z., Rauz, S., Logan, A., & Blanch, R. J. (2020) · Scientific Reports · doi:10.1038/s41598-020-68254-1 · Cited by 30
Formica, M. L., Legeay, S., Bejaud, J., Montich, G. G., Gamboa, G. V. U., Benoît, J., & Palma, S. D. (2020) · Materials Science and Engineering C · doi:10.1016/j.msec.2020.111398 · Cited by 30
Tavakoli, M., Mahboobian, M. M., Nouri, F., & Mohammadi, M. (2021) · Toxicology Mechanisms and Methods · doi:10.1080/15376516.2021.1941461 · Cited by 30
Iskandar, K., Marchin, L., Kodjikian, L., Rocher, M., & Roques, C. G. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14102176 · Cited by 30
Bisht, R., & Rupenthal, I. D. (2016) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2016.1240184 · Cited by 30
Schuerer, N., Stein, E., Inić‐Kanada, A., Pucher, M. E., Hohenadl, C., Bintner, N., Ghasemian, E., Montanaro, J., & Barisani‐Asenbauer, T. (2017) · Cornea · doi:10.1097/ico.0000000000001199 · Cited by 30
Noh, G., Keum, T., Seo, J., Choi, J., Bastola, R., Lamichhane, S., Park, B., Choi, Y. W., & Lee, S. K. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10040208 · Cited by 30
Dludla, S. B. K., Mashabela, L. T., Ng’andwe, B., Makoni, P. A., & Witika, B. A. (2022) · Polymers · doi:10.3390/polym14173580 · Cited by 32
Supe, S., Upadhya, A., Tripathi, S. D., Dighe, V. D., & Singh, K. (2023) · Drug Delivery and Translational Research · doi:10.1007/s13346-022-01281-9 · Cited by 29
Multivalent hyaluronic acid bioconjugates improve sFlt-1 activity in vitro
Altiok, E. I., Santiago-Ortiz, J. L., Svedlund, F. L., Zbinden, A., Jha, A. K., Bhatnagar, D., Loskill, P., Jackson, W. M., Schaffer, D. V., & Healy, K. E. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.03.017 · Cited by 29
Liposomes as potential carriers for ketorolac ophthalmic delivery: formulation and stability issues
Mehanna, M. M., El-Kader, N. A., & Samaha, M. W. (2017) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s2175-97902017000216127 · Cited by 29
Formulation characteristics and in vitro release testing of cyclosporine ophthalmic ointments
Dong, Y., Qu, H., Pavurala, N., Wang, J., Sekar, V., Martinez, M. N., Fahmy, R. M., Ashraf, M., Cruz, C. N., & Xu, X. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.04.042 · Cited by 29
Miyagawa, T., Chen, Z.-Y., Chang, C.-Y., Chen, K.-H., Wang, Y.-K., Liu, G., & Tseng, C. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12050404 · Cited by 29
Navarro‐Partida, J., Altamirano-Vallejo, J. C., la Rosa, A. G., Armendáriz‐Borunda, J., Castro‐Castañeda, C. R., & Santos, A. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13030322 · Cited by 30
Recent Advances in the Excipients Used for Modified Ocular Drug Delivery
Koutsoviti, M., Siamidi, A., Pavlou, P., & Vlachou, M. (2021) · Materials · doi:10.3390/ma14154290 · Cited by 30
Fan, W., Song, M., Li, L., Niu, L., Chen, Y., Han, B., Sun, X., Yáng, Z., Lei, Y., & Chen, X. S. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.121074 · Cited by 29
Nanoceria for ocular diseases: recent advances and future prospects
Cui, W., Wang, Y., Luo, C., Xu, J., Wang, K., Han, H., & Yao, K. (2022) · Materials Today Nano · doi:10.1016/j.mtnano.2022.100218 · Cited by 29
Mirzaeei, S., Taghe, S., Alany, R. G., & Nokhodchi, A. (2022) · Biomedicines · doi:10.3390/biomedicines10081917 · Cited by 29
Metadata
- Authors
- Gaudana, R., Ananthula, H. K., Parenky, A., & Mitra, A. K.
- Affiliations
- University of Missouri–Kansas City (US)
- Corresponding author
- Mitra, Ashim K.
- Venue
- The AAPS Journal
- Published
- 2010-05-01
- Volume
- 12
- Issue
- 3
- Pages
- 348-360
- ISSN
- 1550-7416 (ISSN-L)
- PMC
- PMC2895432
- OpenAlex
- W2018516156
- Cited by
- 1,406
- References
- 256
- Citations by year
- 2026: 114 · 2025: 114 · 2024: 98 · 2023: 118 · 2022: 110 · 2021: 126 · 2020: 116 · 2019: 93 · 2018: 100 · 2017: 96 · 2016: 82 · 2015: 60 · 2014: 54 · 2013: 58 · 2012: 32
- FWCI
- 4.89
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- The AAPS Journal (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Eye Institute (R01EY009171, R01EY10659-12, R01EY010659, R01-EY09171-14)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Keywords
- ocular drug delivery, blood-aqueous barrier, blood-retinal barrier, cornea, sclera, retina, choroidal blood flow, lymphatic clearance, efflux pumps, influx transporters, nanoparticles, nanomicelles, liposomes, microemulsions, bioadhesive gel, fibrin glue, sustained drug release, topical drug delivery, posterior segment, anterior segment
- MeSH terms
- Administration, Topical, Colloids, Eye, Half-Life, Humans, Iontophoresis, Melanins, Pharmacokinetics, Ultrasonics, Drug Delivery Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review